...
search icon
envb-img

Enveric Biosciences Inc Share Price

ENVB
NAQ
$2.37
-$0.26
(-9.89%)
1D
Industry: Biotechnology Sector: Health Care

Enveric Biosciences Inc Analyst Forecast

Enveric Biosciences Inc Share Price Chart

Enveric Biosciences Inc Key Stock Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$3.66M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
84.34K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.28
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$2.59 L
$37.2 H
$2.37

About Enveric Biosciences Inc, Common Stock

Enveric Biosciences, Inc., a biotechnology company, engages in the development of small-molecule therapeutics for the treatment of anxiety, depression, and addiction disorders. The company offers product candidates are EB-002, an active metabolite of psilocybin, which is in preclinical development stage for the treatment of anxiety disorders; and EB-003 that is in preclinical development stage for the treatment mental health. It also focuses on the development of cannabinoid conjugate molecules for the treatment of pain and cancer. The company was founded in 2020 and is headquartered in Cambridge, Massachusetts. more

Industry: BiotechnologySector: Health Care

Enveric Biosciences Inc Stock Returns

Time FrameENVBSectorS&P500
1-Week Return-18.56%0.06%-2.06%
1-Month Return-41.34%-2.06%-2.06%
3-Month Return-60.76%6.1%1.11%
6-Month Return-82.83%18.64%7.13%
1-Year Return-88.24%5.25%11.74%
3-Year Return-99.55%17.35%65.43%
5-Year Return-99.99%33.7%73.53%
10-Year Return-100%143.77%266.66%

Enveric Biosciences Inc Financials

Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue39.91M----[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Cost of Revenue120.87K681.61K435.20K408.03K337.49K[{"date":"2020-12-31","value":17.73,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":63.85,"profit":true},{"date":"2023-12-31","value":59.86,"profit":true},{"date":"2024-12-31","value":49.51,"profit":true}]
Gross Profit(120.87K)(681.61K)(435.20K)(408.03K)(337.49K)[{"date":"2020-12-31","value":-12087200,"profit":false},{"date":"2021-12-31","value":-68161200,"profit":false},{"date":"2022-12-31","value":-43520100,"profit":false},{"date":"2023-12-31","value":-40803000,"profit":false},{"date":"2024-12-31","value":-33748900,"profit":false}]
Gross Margin(0.30%)----[{"date":"2020-12-31","value":-0.3,"profit":false},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Operating Expenses5.50M25.26M19.53M16.04M9.29M[{"date":"2020-12-31","value":21.76,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":77.29,"profit":true},{"date":"2023-12-31","value":63.49,"profit":true},{"date":"2024-12-31","value":36.79,"profit":true}]
Operating Income(5.62M)(25.94M)(19.96M)(16.45M)(9.63M)[{"date":"2020-12-31","value":-561731700,"profit":false},{"date":"2021-12-31","value":-2594450200,"profit":false},{"date":"2022-12-31","value":-1996144400,"profit":false},{"date":"2023-12-31","value":-1644844000,"profit":false},{"date":"2024-12-31","value":-963226600,"profit":false}]
Total Non-Operating Income/Expense(1.69M)(30.50M)(1.20K)(811.37K)66.43K[{"date":"2020-12-31","value":-2548.04,"profit":false},{"date":"2021-12-31","value":-45910.63,"profit":false},{"date":"2022-12-31","value":-1.8,"profit":false},{"date":"2023-12-31","value":-1221.43,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]
Pre-Tax Income(6.86M)(56.43M)(19.96M)(17.26M)(9.57M)[{"date":"2020-12-31","value":-686467600,"profit":false},{"date":"2021-12-31","value":-5643170100,"profit":false},{"date":"2022-12-31","value":-1995739300,"profit":false},{"date":"2023-12-31","value":-1726281900,"profit":false},{"date":"2024-12-31","value":-956605700,"profit":false}]
Income Taxes(477.73K)(7.45M)(1.49M)28.91K8.93K[{"date":"2020-12-31","value":-1652.31,"profit":false},{"date":"2021-12-31","value":-25783.57,"profit":false},{"date":"2022-12-31","value":-5139.76,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":30.89,"profit":true}]
Income After Taxes(6.39M)(48.98M)(18.47M)(17.29M)(9.57M)[{"date":"2020-12-31","value":-638694500,"profit":false},{"date":"2021-12-31","value":-4897689600,"profit":false},{"date":"2022-12-31","value":-1847133300,"profit":false},{"date":"2023-12-31","value":-1729173200,"profit":false},{"date":"2024-12-31","value":-957498700,"profit":false}]
Income From Continuous Operations(6.86M)(48.98M)(18.47M)(22.53M)(9.57M)[{"date":"2020-12-31","value":-686467600,"profit":false},{"date":"2021-12-31","value":-4897689600,"profit":false},{"date":"2022-12-31","value":-1847133300,"profit":false},{"date":"2023-12-31","value":-2253369800,"profit":false},{"date":"2024-12-31","value":-957498700,"profit":false}]
Income From Discontinued Operations-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income(6.86M)(48.98M)(18.50M)(17.29K)(9.57M)[{"date":"2020-12-31","value":-686467600,"profit":false},{"date":"2021-12-31","value":-4897689600,"profit":false},{"date":"2022-12-31","value":-1850434700,"profit":false},{"date":"2023-12-31","value":-1729173,"profit":false},{"date":"2024-12-31","value":-957498700,"profit":false}]
EPS (Diluted)-(99.38)-(20.59)(4.44)[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-9937.5,"profit":false},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":-2059.5,"profit":false},{"date":"2024-12-31","value":-444,"profit":false}]

Enveric Biosciences Inc Ratios

Enveric Biosciences Inc Liquidity Ratios

These ratios help you determine the liquidity of the company. Higher is better.

ENVB
Cash Ratio 4.15
Current Ratio 4.60

Enveric Biosciences Inc Asset Efficiency Ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

ENVB
ROA (LTM) -129.73%
ROE (LTM) -261.96%

Enveric Biosciences Inc Liability Ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

ENVB
Debt Ratio Lower is generally better. Negative is bad. 0.21
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.79

Enveric Biosciences Inc Valuation Ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

ENVB
Trailing PE NM
Forward PE 23.09
P/S (TTM) 0.08
P/B 1.11
Price/FCF NM
EV/R 1.76
EV/Ebitda 0.29

FAQs

What is Enveric Biosciences Inc share price today?

Enveric Biosciences Inc (ENVB) share price today is $2.37

Can Indians buy Enveric Biosciences Inc shares?

Yes, Indians can buy shares of Enveric Biosciences Inc (ENVB) on Vested. To buy

from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in ENVB stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Enveric Biosciences Inc be purchased?

Yes, you can purchase fractional shares of Enveric Biosciences Inc (ENVB) via the Vested app. You can start investing in Enveric Biosciences Inc (ENVB) with a minimum investment of $1.

How to invest in Enveric Biosciences Inc shares from India?

You can invest in shares of Enveric Biosciences Inc (ENVB) via Vested in three simple steps:

  • Click on Sign Up or Invest in ENVB stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Enveric Biosciences Inc shares
What is Enveric Biosciences Inc 52-week high and low stock price?

The 52-week high price of Enveric Biosciences Inc (ENVB) is $37.2. The 52-week low price of Enveric Biosciences Inc (ENVB) is $2.59.

What is Enveric Biosciences Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Enveric Biosciences Inc (ENVB) is

What is Enveric Biosciences Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Enveric Biosciences Inc (ENVB) is 1.11

What is Enveric Biosciences Inc dividend yield?

The dividend yield of Enveric Biosciences Inc (ENVB) is 0.00%

What is the Market Cap of Enveric Biosciences Inc?

The market capitalization of Enveric Biosciences Inc (ENVB) is $3.66M

What is Enveric Biosciences Inc's stock symbol?

The stock symbol (or ticker) of Enveric Biosciences Inc is ENVB

How Can Investors Use Enveric Biosciences Inc Share Price Data for Long-Term Investment Decisions?

Consider the share price of Enveric Biosciences Inc as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Enveric Biosciences Inc has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from Enveric Biosciences Inc shares for Indian investors?

When investing in Enveric Biosciences Inc shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Enveric Biosciences Inc stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare Enveric Biosciences Inc share price with other stocks in the same sector?

Rather than merely checking the share price of Enveric Biosciences Inc and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Enveric Biosciences Inc stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top